Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein Inc. (symbol: HSIC) is the world's largest provider of healthcare products and services to office-based dental, animal health, and medical practitioners. As a Fortune 500® company and a member of the S&P 500® and NASDAQ 100® indexes, Henry Schein employs more than 18,000 team members and serves over one million customers globally. The company's offerings extend to dental laboratories, government and institutional healthcare clinics, and other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, offering a comprehensive selection of more than 100,000 branded products and private-label products, as well as over 150,000 additional products available as special-order items.
The company is organized into two main segments: Healthcare Distribution and Technology & Value-Added Services. The Healthcare Distribution segment focuses on distributing consumable products, small equipment, and laboratory products. The Technology & Value-Added Services segment provides innovative software solutions and other technology services designed to help healthcare practitioners run their practices more efficiently and deliver high-quality care.
In recent years, Henry Schein has achieved significant milestones, including expanding its product range and forming strategic partnerships to enhance its service offerings. The company continues to innovate with exclusive technology solutions aimed at improving practice management and patient care.
Henry Schein, a leading provider of healthcare solutions, will release its fourth quarter and full-year 2021 financial results on February 15, 2022, prior to market opening. A live webcast of the earnings call will begin at 10:00 a.m. ET, featuring speeches from executives including CEO Stanley M. Bergman and CFO Steven Paladino. The call will be accessible via the company's webcast link. Henry Schein operates globally, supporting over 1 million customers with a comprehensive range of healthcare solutions.
Henry Schein, Inc. (NASDAQ: HSIC) announced the retirement of CFO Steven Paladino, effective April 29, 2022, after 35 years with the company. Ronald N. South, currently Vice President of Corporate Finance, will succeed him. Paladino will remain on the Board of Directors and serve as an advisor post-retirement. Under Paladino's leadership, the company experienced significant growth, achieving a compound annual growth rate of approximately 12% in net sales and earnings per share since going public in 1995. The transition aims to ensure continuity in financial management.
Henry Schein, the leading provider of healthcare solutions for dental and medical practitioners, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 9:45 a.m. Eastern time. The event will be accessible via live webcast on Henry Schein's investor relations website. As a FORTUNE 500 Company and member of the S&P 500 index, Henry Schein reported sales of $10.1 billion in 2020, with a consistent compound annual growth rate of 12% since going public in 1995. For additional details, visit their website.
Henry Schein, Inc. (Nasdaq: HSIC) announced that CEO Stanley M. Bergman received an award from The National Hispanic Foundation for his efforts in promoting health equity for Hispanic communities. The recognition occurred during the 18th Annual New York Hispanic Health Professional Student Scholarship Gala. Bergman emphasized the company's commitment to reducing health disparities and improving access to healthcare. Over three decades, Henry Schein has partnered with organizations to foster diversity in healthcare and support the recruitment of Hispanic professionals.
Henry Schein (NASDAQ: HSIC) has signed a cooperative contract with OMNIA Partners to enhance procurement access for K-12, higher education, and healthcare sectors. This agreement includes a master contract with the University of California, facilitating medical supply distribution to eligible public agencies. The offerings include point-of-care diagnostic testing, PPE, and various medical products. The contract aims to streamline procurement, increase savings, and improve health services accessibility for students and staff.
Henry Schein (NASDAQ: HSIC) has donated over
Henry Schein has appointed Scott Serota, former President and CEO of Blue Cross Blue Shield Association, to its Board of Directors effective immediately. Serota, who expanded BCBSA's membership from 65 million to over 100 million, is expected to contribute his healthcare expertise to advance the company's strategic goals. Meanwhile, Barry Alperin will retire from the Board in May, adhering to the director resignation policy upon reaching 80 years of age. This change aims to bolster leadership and a focus on public health challenges.
Henry Schein Orthodontics has launched Studio Pro™ 4.0, an advanced web-based treatment planning software for Reveal® Clear Aligners. This new platform, integrated with the DDX® Case Management Portal, enables providers to customize treatment plans with over 25 new features, enhancing user experience for practitioners of all skill levels. Phil Prentice, President of Henry Schein’s Orthodontics Group, emphasized the software's role in simplifying workflows. The software aims to improve patient communication and treatment control, marking a significant advancement in orthodontic technology.
FAQ
What is the current stock price of Henry Schein (HSIC)?
What is the market cap of Henry Schein (HSIC)?
What does Henry Schein Inc. do?
How many team members does Henry Schein employ?
What segments does Henry Schein operate in?
How many products does Henry Schein offer?
Who are Henry Schein's primary customers?
What kind of technology solutions does Henry Schein provide?
Is Henry Schein a Fortune 500 company?
What stock market indexes is Henry Schein a part of?
How many customers does Henry Schein serve?